Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

20 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Sectral Articles

Stock Commentary - New York - week to Oct 1, 2007

8 October 2007

Sanofi and Chugai to end marketing deal

6 August 2007

Mylan Lab; acebutolol hydrochloride

8 May 1995

EXTENSION TO JAPANESE FORMULARY

11 October 1993

DRUG THERAPY FOR MILD HYPERTENSION FAVORED

16 August 1993

AMERICAN HOME HAS CONFIDENCE FOR 1993

12 April 1993

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • New study shows UCB's Neupro reduces NSBP in RLS patient
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • New study shows UCB's Neupro reduces NSBP in RLS patient
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS